Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | AMLX |
---|---|---|
09:32 ET | 4947 | 2.99 |
09:34 ET | 600 | 3 |
09:36 ET | 22076 | 3.04 |
09:38 ET | 5100 | 3.04 |
09:39 ET | 2543 | 3.04 |
09:41 ET | 6275 | 3.0144 |
09:43 ET | 3874 | 2.995 |
09:45 ET | 3003 | 3 |
09:50 ET | 1475 | 3.002 |
09:52 ET | 1000 | 3.005 |
09:54 ET | 2900 | 3.02 |
09:56 ET | 1122 | 3.03 |
09:57 ET | 1300 | 3.035 |
09:59 ET | 600 | 3.035 |
10:01 ET | 6821 | 3.035 |
10:03 ET | 1200 | 3.05 |
10:06 ET | 1100 | 3.055 |
10:08 ET | 1239 | 3.0559 |
10:10 ET | 400 | 3.055 |
10:12 ET | 900 | 3.055 |
10:14 ET | 600 | 3.055 |
10:15 ET | 3757 | 3.025 |
10:17 ET | 2050 | 3.025 |
10:19 ET | 3780 | 3.045 |
10:21 ET | 2600 | 3.035 |
10:24 ET | 4661 | 3.035 |
10:26 ET | 1486 | 3.025 |
10:28 ET | 1500 | 3.025 |
10:30 ET | 400 | 3.02 |
10:32 ET | 4468 | 3.04 |
10:33 ET | 12867 | 3.07 |
10:35 ET | 2283 | 3.065 |
10:37 ET | 1937 | 3.07 |
10:39 ET | 2577 | 3.05 |
10:42 ET | 1200 | 3.035 |
10:44 ET | 1065 | 3.025 |
10:46 ET | 3000 | 3.02 |
10:48 ET | 2088 | 3.015 |
10:50 ET | 700 | 3.015 |
10:51 ET | 1200 | 3.005 |
10:53 ET | 3357 | 2.995 |
10:55 ET | 1700 | 2.995 |
10:57 ET | 1216 | 2.995 |
11:00 ET | 700 | 2.995 |
11:02 ET | 1700 | 2.995 |
11:04 ET | 2399 | 2.995 |
11:06 ET | 2600 | 3 |
11:08 ET | 1098 | 2.995 |
11:09 ET | 2110 | 2.991 |
11:11 ET | 9555 | 2.99 |
11:13 ET | 500 | 2.995 |
11:15 ET | 600 | 2.995 |
11:18 ET | 1894 | 3.005 |
11:20 ET | 2682 | 3.01 |
11:22 ET | 400 | 3.01 |
11:24 ET | 696 | 3.01 |
11:26 ET | 1200 | 3.015 |
11:27 ET | 800 | 3.02 |
11:29 ET | 1200 | 3.015 |
11:31 ET | 300 | 3.015 |
11:33 ET | 2071 | 3.015 |
11:36 ET | 500 | 3.015 |
11:38 ET | 400 | 3.015 |
11:40 ET | 200 | 3.015 |
11:42 ET | 400 | 3.02 |
11:44 ET | 948 | 3.015 |
11:45 ET | 748 | 3.015 |
11:47 ET | 2110 | 3.015 |
11:49 ET | 696 | 3.02 |
11:51 ET | 302 | 3.015 |
11:54 ET | 1600 | 3.01 |
11:56 ET | 3109 | 3.005 |
11:58 ET | 2293 | 3.015 |
12:00 ET | 1666 | 3.02 |
12:02 ET | 640 | 3.0111 |
12:03 ET | 1110 | 3.015 |
12:05 ET | 3644 | 3.005 |
12:07 ET | 3826 | 3.035 |
12:09 ET | 2216 | 3.03 |
12:12 ET | 200 | 3.03 |
12:14 ET | 2155 | 3.04 |
12:16 ET | 1392 | 3.035 |
12:18 ET | 700 | 3.035 |
12:20 ET | 200 | 3.035 |
12:21 ET | 523 | 3.04 |
12:23 ET | 1505 | 3.04 |
12:25 ET | 200 | 3.05 |
12:27 ET | 400 | 3.045 |
12:30 ET | 1610 | 3.04 |
12:32 ET | 8122 | 3.04 |
12:34 ET | 5373 | 3.055 |
12:36 ET | 1000 | 3.06 |
12:38 ET | 400 | 3.055 |
12:39 ET | 4427 | 3.06 |
12:41 ET | 1800 | 3.07 |
12:43 ET | 800 | 3.06 |
12:45 ET | 1810 | 3.055 |
12:48 ET | 400 | 3.055 |
12:50 ET | 519 | 3.06 |
12:52 ET | 2248 | 3.05 |
12:54 ET | 200 | 3.045 |
12:56 ET | 2195 | 3.03 |
12:57 ET | 462 | 3.035 |
12:59 ET | 1436 | 3.035 |
01:01 ET | 300 | 3.035 |
01:03 ET | 2153 | 3.05 |
01:06 ET | 1576 | 3.05 |
01:10 ET | 100 | 3.05 |
01:12 ET | 400 | 3.045 |
01:14 ET | 420 | 3.045 |
01:15 ET | 838 | 3.05 |
01:17 ET | 872 | 3.06 |
01:19 ET | 3361 | 3.055 |
01:21 ET | 300 | 3.055 |
01:24 ET | 300 | 3.05 |
01:26 ET | 9586 | 3.055 |
01:28 ET | 1813 | 3.05 |
01:30 ET | 2977 | 3.03 |
01:32 ET | 2007 | 3.025 |
01:33 ET | 400 | 3.03 |
01:35 ET | 400 | 3.03 |
01:37 ET | 400 | 3.025 |
01:39 ET | 1342 | 3.025 |
01:44 ET | 7803 | 3.0009 |
01:46 ET | 1300 | 3.005 |
01:48 ET | 24705 | 2.99 |
01:50 ET | 1195 | 2.985 |
01:51 ET | 2792 | 2.99 |
01:53 ET | 2961 | 2.985 |
01:55 ET | 400 | 2.99 |
01:57 ET | 4852 | 2.995 |
02:00 ET | 14040 | 2.985 |
02:02 ET | 500 | 2.981 |
02:04 ET | 1817 | 2.985 |
02:06 ET | 5342 | 2.995 |
02:08 ET | 1317 | 2.9992 |
02:09 ET | 1000 | 3 |
02:11 ET | 3072 | 3.005 |
02:13 ET | 1372 | 3.01 |
02:15 ET | 300 | 3.01 |
02:22 ET | 200 | 3.005 |
02:24 ET | 4361 | 3.005 |
02:26 ET | 100 | 3.01 |
02:27 ET | 100 | 3.005 |
02:29 ET | 603 | 3.01 |
02:31 ET | 200 | 3.005 |
02:33 ET | 703 | 3.005 |
02:36 ET | 3900 | 3.005 |
02:38 ET | 8767 | 2.99 |
02:40 ET | 2326 | 3 |
02:42 ET | 100 | 2.995 |
02:44 ET | 768 | 3 |
02:45 ET | 997 | 3 |
02:47 ET | 7624 | 2.995 |
02:49 ET | 24887 | 2.99 |
02:51 ET | 767 | 2.99 |
02:54 ET | 400 | 2.99 |
02:56 ET | 734 | 2.99 |
02:58 ET | 100 | 2.99 |
03:00 ET | 12047 | 2.975 |
03:02 ET | 4728 | 2.97 |
03:03 ET | 5061 | 2.965 |
03:05 ET | 3266 | 2.955 |
03:07 ET | 1042 | 2.955 |
03:09 ET | 31526 | 2.955 |
03:12 ET | 1400 | 2.955 |
03:14 ET | 300 | 2.955 |
03:16 ET | 19632 | 2.965 |
03:18 ET | 7406 | 2.97 |
03:20 ET | 3170 | 2.97 |
03:21 ET | 3132 | 2.955 |
03:23 ET | 6109 | 2.93 |
03:25 ET | 624 | 2.935 |
03:27 ET | 1100 | 2.94 |
03:30 ET | 4524 | 2.93 |
03:32 ET | 700 | 2.935 |
03:34 ET | 1238 | 2.935 |
03:36 ET | 2264 | 2.93 |
03:38 ET | 1391 | 2.935 |
03:39 ET | 1700 | 2.94 |
03:41 ET | 2926 | 2.935 |
03:43 ET | 10693 | 2.945 |
03:45 ET | 3562 | 2.96 |
03:48 ET | 5634 | 2.955 |
03:50 ET | 3791 | 2.945 |
03:52 ET | 3324 | 2.945 |
03:54 ET | 11857 | 2.92 |
03:56 ET | 18030 | 2.93 |
03:57 ET | 13409 | 2.94 |
03:59 ET | 75164 | 2.94 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Amylyx Pharmaceuticals Inc | 206.3M | -1.2x | --- |
Organogenesis Holdings Inc | 377.8M | -22.9x | --- |
Amarin Corporation PLC | 248.2M | -7.2x | --- |
Sinovac Biotech Ltd | 639.9M | -4.9x | --- |
Ironwood Pharmaceuticals Inc | 680.5M | 97.9x | --- |
Coherus BioSciences Inc | 117.5M | -2.6x | --- |
Amylyx Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company. The Company is engaged in the discovery and development of treatments for neurodegenerative diseases. The Company is focused on the development and commercialization of its product candidate: AMX0035 for the treatment of Wolfram syndrome and for the treatment of progressive supranuclear palsy, and AMX0114, the Company’s antisense oligonucleotide targeting calpain-2 for the treatment of amyotrophic lateral sclerosis (ALS). AMX0035 is a dual-unfolded protein response (UPR)-Bax apoptosis inhibitor composed of PB and TURSO (also known as TUDCA). The Company’s Avexitide is an investigational, first-in-class glucagon-like peptide-1 (GLP-1) receptor antagonist that has been evaluated in five clinical trials for post-bariatric hypoglycemia (PBH) and has also been studied in congenital hyperinsulinism (HI), two indications characterized by hyperinsulinemic hypoglycemia.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $206.3M |
---|---|
Revenue (TTM) | $298.8M |
Shares Outstanding | 68.1M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-2.45 |
Book Value | $6.40 |
P/E Ratio | -1.2x |
Price/Sales (TTM) | 0.7 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -59.50% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.